Tryptophan availability for kynurenine pathway metabolism across the life span: Control mechanisms and focus on aging, exercise, diet and nutritional supplements

Neuropharmacology

Volumn 112, Issue , 2017, Pages 248-263

  Badawy, Abdulla A B ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Albumin; Glucose; Indoleamine 2,3 dioxygenase; Non esterified fatty acids; Tryptophan 2,3 dioxygenase

Indexed keywords

3 HYDROXYKYNURENINE; ALBUMIN; ANTHRANILIC ACID; FATTY ACID; GAMMA INTERFERON; GLUCOSE; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; KYNURENINE; PICOLINIC ACID; QUINOLINIC ACID; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR; XANTHURENIC ACID;

AGING; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; BINDING SITE; BIRTH; CARBOHYDRATE INTAKE; CATALYSIS; CIRCADIAN RHYTHM; DEPLETION; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; EXERCISE; FAT INTAKE; FOOD INTAKE; GENE DELETION; HUMAN; IMMUNE STATUS; LIVER; LOADING TEST; METABOLITE; NONHUMAN; OXIDATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN EXPRESSION; PROTEIN INTAKE; REGULATORY MECHANISM; REVIEW; TH1 TH2 BALANCE; TISSUE DISTRIBUTION; VITAMIN DEFICIENCY; ANIMAL; DIET; DIETARY SUPPLEMENT; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; DIET; DIETARY SUPPLEMENTS; EXERCISE; HUMANS; KYNURENINE; METABOLIC NETWORKS AND PATHWAYS; TRYPTOPHAN;

EID: 84949675877     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.11.015     Document Type: Review

References (169)

1. Abbassi-Ghanavati, M., Greer, L.G., Cunningham, G.F., Pregnancy and laboratory studies: a reference table for clinicians. Obstet. Gynecol. 114 (2009), 1326–1331.
2. Alberati-Giani, D., Ricciardi-Castanoli, P., Köhler, C., Cesura, A.M., Regulation of the kynurenine pathway by IFN-γin murine cloned macrophages and microglial cells. Adv. Exp. Med. Biol. 398 (1996), 171–175.
3. Allegri, G., Costa, C., De Antoni, A., A further contribution to the choice of the dose for tryptophan load test. Acta Vitaminol. Enzymol. (Milano) 32 (1978), 163–166.
4. Altman, K., Greengard, O., Correlation of kynurenine excretion with liver tryptophan pyrrolase levels in disease and after hydrocortisone induction. J. Clin. Investig. 45 (1966), 1527–1534.
5. Badawy, A.A.-B., Minireview – the functions and regulation of tryptophan pyrrolase. Life Sci. 21 (1977), 755–768.
6. Badawy, A.A.-B., Possible involvement of the enhanced tryptophan pyrrolase activity in the corticosterone and starvation-induced increases in concentrations of nicotinamide-adenine dinucleotides (phosphates) in rat liver. Biochem. J. 196 (1981), 217–224.
7. Badawy, A.A.-B., Effects of pregnancy on tryptophan metabolism and disposition in the rat. Biochem. J. 255 (1988), 369–372.
8. Badawy, A.A.-B., Tryptophan metabolism in alcoholism. Nutr. Res. Rev. 15 (2002), 123–152.
9. Badawy, A.A.-B., Plasma free tryptophan revisited: what you need to know and do before measuring it. J. Psychopharmacol. 24 (2010), 809–815.
10. Badawy, A.A.B., Tryptophan: the key to boosting brain serotonin synthesis in depressive illness. J. Psychopharmacol. 27 (2013), 878–893.
11. Badawy, A.A.-B., The tryptophan utilisation concept in pregnancy. Obstet. Gynecol. Sci. 57 (2014), 249–259.
12. Badawy, A.A.-B., Pellagra and alcoholism: a biochemical perspective. Alcohol Alcohol 49 (2014), 238–250.
13. Badawy, A.A.-B., Tryptophan metabolism, disposition and utilization in pregnancy. Biosci. Rep., 2015, 10.1042/BSR20150197) Identifier: e00261.
14. Badawy, A.A.-B., Dougherty, D.M., Standardization of formulations for the acute amino acid depletion and loading tests. J. Psychopharmacol. 29 (2015), 363–371.
15. Badawy, A.A.-B., Evans, M., The regulation of rat liver tryptophan pyrrolase by its cofactor haem – experiments with haematin and 5-aminolaevulinate and comparison with the substrate and hormonal mechanisms. Biochem. J. 150 (1975), 511–520.
16. Badawy, A.A.-B., Evans, M., Tryptophan plus a pyrrolase inhibitor for depression. Lancet, 869, 1975.
17. Badawy, A.A.-B., Evans, M., The regulation of rat liver tryptophan pyrrolase activity by reduced nicotinamide-adenine dinucleotide (phosphate): experiments with glucose and nicotinamide. Biochem. J. 156 (1976), 381–390.
18. Badawy, A.A.-B., Evans, M., Animal liver tryptophan pyrrolases – absence of hormonal induction mechanism from species sensitive to tryptophan toxicity. Biochem. J. 158 (1976), 79–88.
19. Badawy, A.A.B., Morgan, C.J., Tryptophan and tryptophan pyrrolase in haem regulation – the role of lipolysis and direct displacement of serum protein-bound tryptophan in the opposite effects of administration of endotoxin, morphine, palmitate, salicylate and theophylline on rat liver 5-aminolaevulinate synthase activity and the haem saturation of tryptophan pyrrolase. Biochem. J. 206 (1982), 451–460.
20. Badawy, A.A.-B., Morgan, C.J., Rapid isocratic liquid chromatographic separation and quantification of tryptophan and six kynurenine metabolites in biological samples with ultraviolet and fluorimetric detection. Int. J. Tryptophan Res. 3 (2010), 175–186.
21. Badawy, A.A.-B., Punjani, N.F., Evans, M., Unsuitability of control sucrose or glucose in studies of the effects of chronic ethanol administration on brain 5-hydroxytryptamine metabolism. J. Pharmacol. Methods 3 (1979), 167–171.
22. Badawy, A.A.-B., Punjani, N.F., Evans, C.M., Evans, M., Inhibition of rat brain tryptophan metabolism by ethanol withdrawal and possible involvement of the enhanced liver tryptophan pyrrolase activity. Biochem. J. 192 (1980), 449–455.
23. Badawy, A.A.-B., Punjani, N.F., Evans, M., The role of liver tryptophan pyrrolase in the opposite effects of chronic administration and subsequent withdrawal of drugs of dependence on rat brain tryptophan metabolism. Biochem. J. 196 (1981), 161–170.
24. Badawy, A.A.-B., Welch, A.N., Morgan, C.J., Tryptophan pyrrolase in haem regulation: the mechanism of the opposite effects of tryptophan on rat liver 5-aminolaevulinate synthase activity and the haem saturation of tryptophan pyrrolase. Biochem. J. 198 (1981), 309–314.
25. Badawy, A.A.-B., Welch, A.N., Morgan, C.J., Tryptophan pyrrolase in haem regulation: the mechanisms of the enhancement of rat liver 5-aminolaevulinate synthase activity by starvation and of the glucose effect on induction of the enzyme by 2-allyl-2-isopropylacetamide. Biochem. J. 206 (1982), 441–449.
26. Badawy, A.A.-B., Morgan, C.J., Davis, N.R., Dacey, A., High-fat diets increase tryptophan availability to the brain: importance of choice of the control diet. Biochem. J. 217 (1984), 863–864.
27. Badawy, A.A.-B., Morgan, C.J., Turner, J.A., Application of the Phenomenex EZ:faast™ amino acid analysis kit for rapid gas-chromatographic determination of concentrations of plasma tryptophan and its brain uptake competitors. Amino Acids 34 (2008), 587–596.
28. m aldehyde dehydrogenase activity, elevate blood acetaldehyde concentration and induce aversion to alcohol. Alcohol Alcohol​. 46 (2011), 651–660.
29. Badawy, A.A.-N., Lake, S.L., Dougherty, D.M., Mechanisms of the pellagragenic effects of leucine: stimulation of hepatic tryptophan oxidation by administration of branched-chain amino acids to healthy human volunteers and the role of plasma free tryptophan and total kynurenines. Int. J. Tryptophan. Res. 7 (2014), 23–32.
30. Baertl, J.M., Placko, R.P., Graham, G.G., Serum proteins and plasma free amino acids in severe malnutrition. Am. J. Clin. Nutr. 27 (1974), 733–742.
31. Batabyal, D., Yeh, S.-R., Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase. J. Am. Chem. Soc. 129 (2007), 15690–15701.
32. Bender, D.A., Inhibition in vitro of the enzymes of the oxidative pathway of tryptophan metabolism and of nicotinamide nucleotide synthesis by benserazide, carbidopa and isoniazid. Biochem. Pharmacol. 29 (1980), 707–712.
33. Bender, D., Biochemistry of tryptophan in health and disease. Molec. Asp. Med. 6 (1983), 101–197.
34. Bohney, J.P., Feldhoff, R.C., Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin. Biochem. Pharmacol. 43 (1992), 1829–1834.
35. Bonaccorso, S., Lin, A., Song, C., Verkerk, R., Kenis, G., Bosmans, E., Scharpe, S., Vandewoude, M., Dossche, A., Maes, M., Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer's disease (DAT): lower plasma tryptophan availability to the brain in the elderly and increased serum ilterleukin-6 in DAT. Aging Clin. Exp. Res. 10 (1998), 316–323.
36. Braidy, N., Guillemin, G.J., Mansour, H., Chan-Ling, T., Grant, R., Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. FEBS J. 278 (2011), 4425–4434.
37. Brown, R.R., Thornton, M.J., Price, J.M., The effect of vitamin supplementation on the urinary excretion of tryptophan metabolites by pregnant women. J. Clin. Investig. 40 (1961), 617–623.
38. Burns, E.M., Buschmann, M.B.T., Kruckeberg, T.W., Gaetano, P.K., Meyer, J.N., Blood-brain barrier, aging, brain blood flow, and sleep. Camey, A.L., Anderson, E.M., (eds.) Adv. Neurol. 30, Chapter 22: Diagnosis and Treatment of Brain Lschemia, 1991, Raven Press, New York, 301–306.
39. Caballero, B., Gleason, R.E., Wurtman, R.J., Plasma amino acid concentrations in healthy elderly men and women. Am. J. Clin. Nutr. 53 (1991), 1249–1252.
40. Capuron, L., Moranis, A., Combe, N., Cousson-Gélie, F., Fuchs, D., De Smedt-Peyrusse, V., Barberger-Gateau, P., Layé, D., Vitamin E status and quality of life in the elderly: influence of inflammatory processes. Br. J. Nutr. 102 (2009), 1390–1394.
41. Chandra, R.K., Nutrition and the immune system: an introduction. Am. J. Clin. Nutr. 66 (1997), 460S–463S.
42. Chaouloff, F., Elghosi, J.L., Guezennec, Y., Laude, D., Effect of conditioned running on plasma, liver and brain tryptophan and on brain 5-hydroxytryptamine metabolism of the rat. Br. J. Pharmacol. 86 (1985), 33–41.
43. Chiancone, F.M., Enzyme activities of the tryptophan → nicotinic acid path in physiopathology. Ital. J. Biochem. 13 (1964), 1–30.
44. Comai, S., Costa, C.V.L., Ragazzi, E., Bertazzo, A., Allegri, G., The effect of age on the enzyme activities of tryptophan metabolism along the kynurenine pathway in rats. Clin. Chim. Acta 360 (2005), 67–80.
45. Cook, J.C., Pogson, C.I., Smith, S.A., Indoleamine 2,3-dioxygenase: a new, rapid sensitive radiometric assay and its application to the study of the enzyme in rat tissues. Biochem. J. 189 (1980), 461–466.
46. 6 and nicotinamide in aged subjects. Acta Vitaminol. Enzymol. (Milano) 29 (1975), 140–144.
47. Curzon, G., Friedel, J., Knott, P.J., The effect of fatty acids on the binding of tryptophan to plasma protein. Nature 242 (1973), 198–200.
48. Curzon, G., Knott, P.J., Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Br. J. Pharmacol. 50 (1974), 197–204.
49. Curzon, G., Knott, P.J., Rapid effects of environmental disturbance on rat plasma unesterified fatty acid and tryptophan concentrations and their prevention by antilipolytic drugs. Br. J. Pharmacol. 54 (1975), 389–396.
50. Davis, J.M., Bailey, S.P., Woods, J.A., Galiano, F.J., Hamilton, M.T., Bartoli, W.P., Effects of carbohydrate feeding on plasma free tryptophan and branched-chain amino acids during prolonged cycling. Eur.J. Appl. Physiol. 65 (1992), 513–519.
51. De Antoni, A., Carretti, N., Costa, C., D'Antona, N., Bertolin, A., Allegri, G., Triptofano totale e libero nel siero di madri al momento del parto e dei rispettivi neonati (Serum total and free tryptophan concentration in mothers at delivery and in their newborn babies). Giorn. It. Chim. Clin. 5 (1980), 71–77.
52. De Antoni, A., Allegri, G., Costa, C., Vanzan, S., Bertolin, A., Carretti, N., Zanardo, V., Total and free tryptophan levels in serum of newborn infants. Relationship with the serotonin and nicotinic acid pathways. Acta Vitaminol. Enzymol. 2 (1980), 17–20.
53. Demling, J., Langer, K., Mehr, M.Q., Age dependence of large neutral amino acid levels in plasma. Adv. Exp. Med. Biol. 398 (1996), 579–662.
54. Doornboss, B., Hormones, Monoamines and Peripartum Affective Disorders. Dissertation, 2009, University of Groningen ISBN printed version: 978-=90-367-4046-3 and electronic version: 978-90-367-4047-0.
55. Efimov, I., Basran, J., Sun, X., Chauhan, N., Chapman, S.K., Mowat, C.G., Raven, E.L., The mechanism of substrate inhibition in human indoleamine 2,3-dioxygenase. J. Am. Chem. Soc. 134 (2012), 3034–3041.
56. Elahy, M., Jackaman, C., Mamo, J.C.L., Lam, V., Dhaliwal, S.S., Giles, C., Nelson, D., Takechi, R., Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun. Aging, 12, 2015, 2, 10.1186/s12979-015-0029-9.
57. Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M.C., Ouccetti, P., T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9 (2002), 1069–1077.
58. Fernstrom, J.D., Wurtman, R.J., Control of brain serotonin levels by the diet. Adv. Biochem. Psychopharmacol. 11 (1974), 133–142.
59. Fernstrom, J.D., Fernstrom, M.H., Grubb, P.E., Twenty-four-hour variations in rat blood and brain levels of the aromatic and branched-chain amino acids: chronic effects of dietary protein content. Metabolism 36 (1987), 643–650.
60. Frazee, D.R., Ghosh, D., Tryptophan pyrrolase as a function of sex and development in mice. Biochem. Biophys. Res. Commun. 65 (1975), 1013–1017.
61. Fuchs, D., Möller, A.A., Reibnegger, G., Werner, E.R., Werner-Felmayer, G., Dierich, M.P., Wachter, H., Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol. Lett. 28 (1991), 207–212.
62. Fukagawa, N.K., Minaker, K.L., Rowe, J.W., Young, V.R., Plasma tryptophan and total neutral amino acid levels in men: influence of hyperinsulinemia and age. Metabolism 36 (1987), 683–686.
63. Fukunaga, M., Yamamoto, Y., Kawasoe, M., Arioka, Y., Murakami, Y., Hoshi, M., Saito, K., Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis. J. Histochem. Cytochem. 60 (2012), 854–860.
64. Ghafoorunissa, Narasinga Rao, B.S., Effect of leucine on enzymes of the tryptophan-niacin metabolic pathway in rat liver and kidney. Biochem. J. 134 (1973), 425–430.
65. Green, A.R., Curzon, G., Effect of hydrocortisone and immobilization on tryptophan metabolism in brain and liver of rats of different ages. Biochem. Pharmacol. 24 (1975), 713–716.
66. Green, A.R., Bloomfield, M.R., Woods, H.F., Seed, M., Metabolism of an oral tryptophan load by women and evidence against the induction of tryptophan pyrrolase by oral contraceptives. Br. J. Clin. Pharmacol. 5 (1978), 233–241.
67. Green, A.R., Aronson, J.K., Curzon, G., Woods, H.F., Metabolism of an oral tryptophan load. I: effects of dose and pretreatment with tryptophan. Br. J. Clin. Pharmacol. 10 (1980), 603–610.
68. Green, A.R., Woods, H.F., Joseph, M.H., Tryptophan metabolism in the isolated perfused liver of the rat: effects of tryptophan concentration, hydrocortisone and allopurinol on tryptophan pyrrolase activity and kynurenine formation. Br. J. Pharmacol. 57 (1976), 103–114.
69. Green, A.R., Aronson, J.K., Cowen, P.J., The pharmacokinetics of L-tryptophan following its intravenous and oral administration. Br. J. Clin. Pharmacol. 20 (1985), 317–321.
70. Greengard, O., The role of coenzymes, cortisone and RNA in the control of liver enzyme levels. Adv. Enzyme Reg. 1 (1963), 61–76.
71. Halonen, M., Lohman, I.C., Stern, D.A., Spangenberg, A., Anderson, D., Moblay, S., Cano, K., Peck, M., Wright, A.L., Th1/Th2 patterns and balance in cytokine production in the parents and infants of a large birth cohort. J. Immunol. 182 (2009), 3285–3293.
72. Heyes, M.P., Morrison, P.F., Quantification of local de novo synthesis versus blood contribution to quinolinic acid concentrations in brain and systemic tissues. J. Neurochem. 68 (1997), 280–288.
73. Horowitz, J.F., Klein, S., Lipid metabolism during endurance exercise. Am. J. Clin. Nutr. 72:Suppl. l (2000), 558S–563S.
74. Huether, G., Hajak, G., Reimer, A., Poeggeler, B., Blömer, M., Rodenbeck, A., Rüther, E., The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacol 109 (1992), 422–432.
75. Ito, Y., Yonekura, R., Maruta, K., Koike, T., Nakagami, Y., Shibata, K., Saito, K., Nagamura, Y., Tryptophan metabolism was accelerated by exercise in rat. Adv. Exp. Med. Biol. 527 (2003), 531–535.
76. Ito, Y., Yonekura, R., Kobayashi, C., Saito, K., Oguri, Y., Kawai, K., Teradaira, R., Nagamura, Y., Relationship between serum kynurenine concentration and exercise performance. Int. Congr. Ser. 1304 (2007), 167–170.
77. Jonetz-Mentzel, LWiedemann, G., Establishment of reference ranges for cortisol in neonates, infants, children and adolescents. Eur. J. Clin. Chem. Clin. Biochem. 31 (1993), 525–529.
78. Kamimura, S., Katsuto, E., Sekiba, K., Tryptophan and its metabolite concentrations in human plasma and breast milk during the perinatal period. Acta Med. Okayama 45 (1991), 101–106.
79. Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., Nakamura, T., Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behaviour in mice. Molec. Brain, 2, 2009, 8, 10.1086/1756-606-2-8.
80. Kanai, M., Nakamura, T., Funakoshi, H., Identification and characterization of novel variants of the tryptophan 2,3-dioxygenase gene: differential regulation in the mouse nervous system during development. Neurosci. Res. 64 (2009), 111–117.
81. Kiank, C., Zeden, J.-P., Drude, S., Domanska, G., Fusch, G., Otten, W., Schuett, C., Psychological stress-induced IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans. PLoS One, 5, 2010, e11825.
82. Knott, P.J., Curzon, G., Free tryptophan in plasma and brain tryptophan metabolism. Nature 239 (1972), 452–453.
83. Kolodziei, L.R., Paleolog, E.M., Williams, R.O., Kynurenine metabolism in health and disease. Amino Acids 41 (2011), 1173–1183.
84. Kragh-Hansen, U., Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin. Biochem. J. 273 (1991), 641–644.
85. Ku, Y., Rogers, Q.R., Harper, A.E., Effects of thyroxine and cortisol on liver threonine dehydratase and tryptophan pyrrolase in rats fed a high protein diet. Exp. Biol. Med. 130 (1969), 56–563.
86. Kudo, Y., Boyd, C.A.R., The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase by human placental explants. J. Physiol. 531:2 (2001), 417–423.
87. Liao, M., Pabarcus, M.K., Wang, Y., Hefner, C., Maltby, D.A., Medzihradszky, K.F., Salas-Castillo, S.P., Yan, J., Maher, J.J., Correia, M.A., Impaired dexamethasone-mediated induction of tryptophan 2,3-dioxygenase in heme-deficient rat hepatocytes: translational control by a hepatic eIF2_kinase, the heme-regulated inhibitor. J. Pharmacol. Exp. Ther. 323 (2007), 979–989.
88. Lieberman, H.R., Askew, E.W., Hoyt, R.W., Shukitt-Hale, B., Sharp, M.A., Effects of 30 days of undernutrition on plasma neurotransmitter precursors, other amino acids, and behaviour. J. Nutr. Biochem. 8 (1997), 19–126.
89. Lipsett, D., Madras, B.K., Wurtman, R.J., Munro, H.N., Serum tryptophan level after carbohydrate ingestion: selective decline in non-albumin-bound tryptophan coincident with reduction in serum free fatty acids. Life Sci. 12 (1973), 57–64.
90. Lusyati, S., Hulzebos, C.V., Zandvoort, J., Sauer, P.J.J., Levels of 25 cytokines in the first seven days of life in newborn infants. BMC Res. Notes, 6, 2013, 547.
91. Maltos, A.L., Portari, G.V., Moraes, G.V., Monteiro, M. C. Rodrigues, Vannucch, H., Ferreira da Cunha, D., Niacin metabolism and indoleamine 2,3-dioxygenase activation in malnourished patients with flaky paint dermatosis. Nutrition 51 (2015), 890–892.
92. Mangge, H., Summers, K.L., Zelzer, S., Almer, G., Prassl, R., Schnedl, W.J., Reininghaus, E., Paulmichl, K., Weghuber, D., Fuchs, D., Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity 22 (2014), 195–201.
93. Marcos, A., Nova, E., Montero, A., Changes in the immune system are conditioned by nutrition. Eur. J. Clin. Nutr. 57:Suppl. 1 (2003), 566–569.
94. Melancon, M.O., Lorrain, D., Dionne, I.J., Exercise increases tryptophan availability to the brain in older men age 57–70 Years. Med. Sci. Sports Exerc 44 (2012), 881–887.
95. Metwalli, O.M., Shukry, A.S., Ghali, I., Shukry, I., Ismail, S., El Beshlawi, A., Studies of tryptophan metabolism in protein-energy malnutrition. Gaz. Egypt. Paediat. Assoc. 26 (1977), 57–66.
96. Metz, R., Smith, C., DuHadaway, J.B., Chandler, P., Baban, B., Merlo, L.M.F., Pigott, E., Keough, M.P., Rust, S., Mellor, A.L., Mandik-Nayak, L., Muller, A.J., Prendergast, G.C., IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int. Immunol., 2014, 10.1093/intimm/dxt073.
97. Michael, A.F., Drummond, K.W., Doeden, D., Anderson, J.A., Good, R.A., Tryptophan metabolism in man. J. Clin. Invest 43 (1964), 1730–1746.
98. Mimura, T., Yamada, C., Swendseid, J., Influence of dietary protein levels and hydrocortisone administration on the branched-chain amino acid transaminase activity in rat tissues. J. Nutr. 95 (1968), 493–498.
99. Moffett, J.R., Namboodiri, M.A., Tryptophan and the immune response. Immunol. Cell Biol. 81 (2003), 247–265.
100. Møller, S.E., Effect of various oral protein doses on plasma neutral amino acids. J. Neural Transm. 61 (1985), 183–191.
101. Moniz, C.F., Nicolaides, K.H., Bamforth, F.J., Rodeck, C.H., Normal reference ranges for biochemical substances relating to renal, hepatic, and bone function in fetal and maternal plasma. J. Clin. Pathol. 38 (1985), 468–472.
102. Mooradian, A.D., Effect of aging on the blood-brain barrier. Neurobiol. Aging 9 (1988), 31–39.
103. Morimoto, Y., Zhang, Q., Adachi, K., Increased blood quinolinic acid after exercise in mice: implications for sensation of fatigue after exercise. J. Health Sci. 57 (2011), 367–371.
104. Morita, I., Kawamoto, M., Yoshida, H., Difference in the concentration of tryptophan metabolites between maternal and umbilical foetal blood. J. Chromatogr. Biomed. Appl. 576 (1992), 334–339.
105. Moroni, F., Lombardi, G., Moneti, G., Aldinio, C., The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process. Neurosci. Lett. 47 (1984), 51–55.
106. Munn, D.H., Zhou, M., Attwood, A.J., Bondarev, I., Conway, S.J., Marshall, B., Brown, C., Mellor, A.L., Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998), 1190–1193.
107. Murray, M.F., Langan, M., MacGregor, R.R., Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide. Nutrition 17 (2001), 654–656.
108. Nakamura, T., Niimi, S., Nawa, K., Noda, C., Ichihara, A., Takagit, Y., Anaiq, M., Sakaki, Y., Multihormonal regulation of transcription of the tryptophan 2,3-dioxygenase gene in primary cultures of adult rat hepatocytes with special reference to the presence of a transcriptional protein mediating the action of glucocorticoids. J. Biol. Chem. 262 (1987), 723–733.
109. Nemeth, A.M., Mechanisms controlling changes in tryptophan peroxidase activity in developing mammalian liver. J. Biol. Chem. 234 (1959), 2921–2924.
110. Nemeth, A.M., de la Haba, G., The effect of puromycin on the developmental and adaptive formation of tryptophan pyrrolase. J. Biol. Chem. 237 (1962), 1190–1193.
111. Nishizuka, Y., Hayaishi, O., Studies on the biosynthesis of nicotinamide adenine nucleotides I. enzymatic synthesis of niacin ribonucleotides from 3-hydroxyanthranilic acid in mammalian tissue. J. Biol. Chem. 238 (1963), 3369–3377.
112. Ohta, M., Hirai, N., Ono, Y., Takeda, N., Machida, K., Clinical biochemical evaluation of central fatigue with 24-hour continuous exercise. Jpn. J. Clin. Pathol. 53 (2005), 802–809.
113. 6-deficient rats. Adv. Exp. Med. Biol. 398 (1996), 589–593.
114. Opitz, C.A., Litzenburger, U.M., Opitz, U., Sahm, F., Ochs, K., Lutz, C., The indoleamine-2,3-Dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells. PLoS One, 6, 2011, e19823.
115. Osagawa, N., Hagino, Y., Kotake, Y., Kynurenine aminotransferase and the increase in xanthurenic acid excretion. J. Biochem. (Tokyo) 52 (1962), 162–166.
116. 1-acid glycoprotein: implications for binding of drugs. Ther. Drug Monit. 8 (1986), 259–263.
117. Partridge, W.M., Oldendorf, W.H., Transport of metabolic substrates through the blood- brain barrier. J. Neurochem. 28 (1977), 5–12.
118. Patnaik, S.K., Patnaik, R., Age-related differential induction of tryptophan pyrrolase by hydrocortisone in the liver of male rats. Biochem. Int. 18 (1989), 1221–1228.
119. 14C] tryptophan in the rat. J. Nutr. 112 (1982), 776–781.
120. Pawlak, D., Tankiewicz, A., Matys, T., Buczko, E., Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J. Physiol. Pharmacol. Pol. 54 (2003), 175–189.
121. Peake, J.M., Della Gatta, P., Suzuki, K., Nieman, D.C., Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects. Exerc. Immunol. Rev. 21 (2015), 8–25.
122. Pfefferkorn, E.R., Rebhun, S., Eckel, M., Characterisation of an indoleamine dioxygenase induced by gamma interferon in cultured human fibroblasts. J. Interferon Res. 6 (1986), 267–279.
123. Phipps, D.A., Powell, C., Plasma tryptophan, age and depression. Age Aging 14 (1985), 71–75.
124. Piacentini, M.F., Meeusen, R., Buyse, L., De Schutter, G., De Meirleir, K., Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor. Br. J. Sports Med. 38 (2004), 129–133.
125. Popescu, B.O., Toescu, E.C., Popescu, L.M., Bajenaru, O., Muresanu, D.F., Schultzberg, B., Bogdanović, N., Blood-brain barrier alterations in aging and dementia. J. Neural Sci. 283 (2009), 99–106.
126. Price, J.M., Brown, R.R., Yess, N., Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites. Adv. Metab. Disord. 2 (1965), 159–225.
127. Ravi, V., Johansson, J., Lewander, T., Venizelos, N., Tryptophan transport in human fibroblast cells - a functional characterization. Int. J. Tryptophan Res. 4 (2011), 19–27.
128. Rudman, D., Mattson, D.E., Feller, A.G., Cotter, R., Johnson, R.C., Fasting plasma amino acids in elderly men. Am. J. Clin. Nutr. 49 (1989), 559–566.
129. Sainio, E.L., Sainio, P., Comparison of effects of nicotinic acid or tryptophan on tryptophan 2,3-dioxygenase in acute and chronic studies. Toxicol. Appl. Pharmacol. 102 (1990), 251–258.
130. Saito, K., Seishima, M., Noma, A., Markey, S.P., Heyes, M.P., Cytokine and drug modulation of kynurenine pathway metabolism by blood mononuclear cells. Adv. Exp. Med. Biol. 398 (1996), 161–165.
131. Sakakeeny, L., Roubenoff, R., Obin, M., Fontes, J.D., Benjamin, E.J., Bujanover, Y., Jacques, P.F., Selhub, J., Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults. J. Nutr. 142 (2012), 1280–1285.
132. Salter, M., Bender, D.A., Pogson, C.I., Leucine and tryptophan metabolism in rats. Biochem. J. 225 (1985), 277–281.
133. Salter, M., Knowles, R.G., Pogson, C.I., Quantification of the importance of individual steps in the control of aromatic amino acid metabolism. Biochem. J. 234 (1986), 635–647.
134. Santillan, M.K., Pelham, C.J., Gibson-Corley, K.N., Scroggins, S.M., Pregnant mice lacking indoleamine 2,3-dioxygenase exhibit preeclampsia phenotypes. Physiol. Rep., 3, 2015, e12257, 10.14814/phy2.12257.
135. Sarandakou, A., Giannaki, C.A.G., Malamitsi-Puchner, A., Rizos, D., Hourdaki, E., Protonotariou, E., Phocas, I., Inflammatory cytokines in newborn infants. Mediat. Inflamm. 7 (1998), 309–312.
136. Sarwar, G., Botting, H.G., Collins, M., A comparison of fasting serum amino acid profiles of young and elderly subjects. J. Am. Coll. Nutr. 10 (1991), 668–674.
137. Satyanarayana, U., Rao, B.S.N., Effect of dietary protein levels on some key enzymes of the tryptophan-NAD pathway. Br. J. Nutr. 38 (1977), 39–45.
138. Schimke, R.T., Sweeney, E.W., Berlin, C.M., The roles of synthesis and degradation in the control of rat liver tryptophan pyrrolase. J. Biol. Chem. 240 (1965), 322–331.
139. Schröcksnadel, H., Baier-Bitterlich, G., Dapunt, O., Wachter, H., Fuchs, D., Decreased plasma tryptophan in pregnancy. Obstet. Gynecol. 88 (1996), 47–50.
140. Serrano, A. Jr., Nagayama, F., Activity and partial purification of liver tryptophan pyrrolase in rainbow trout. Nippon. Suisan Gakkaishi Former. Bull. Jpn. Soc. Sei. Fish., 1992, 10.2331/suisan.58.2367.
141. Smith, D., Effect of age on serum tryptophan and urine indican in adults given a tryptophan load test. Eur. J. Drug Metab. Pharmacokinet. 7 (1982), 55–58.
142. Smith, S.A., Pogson, C.I., The metabolism of L-tryptophan by isolated rat liver cells: effect of albumin binding and amino acid competition on oxidation of tryptophan by tryptophan 2,3-dioxygenase. Biochem. J. 186 (1980), 977–986.
143. Sono, M., Taniguchi, T., Watanabe, Y., Hayaishi, O., Indoleamine 2,3-dioxygenase: equilibrium studies of the tryptophan binding to the ferric, ferrous, and co-bound enzymes. J. Biol. Chem. 255 (1980), 1339–1345.
144. Spiegel, E., Spiegel, M., Regulation of mammalian tryptophan pyrrolase activity during development. Exp. Cell Res. 36 (1964), 427–429.
145. Stoy, N., Mackay, C.M., Forrest, C.M., Christofides, J., Egerton, M., Stone, T.W., Darlington, L.G., Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J. Neurochem. 93 (2005), 611–623.
146. Suzuki, S., Toné, S., Takikawa, O., Kubo, T., Kohno, I., Minatogawa, Y., Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem. J. 355 (2001), 425–429.
147. Takikawa, O., Yoshida, R., Kido, R., Hayaishi, O., Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 261 (1986), 3648–3653.
148. Takikawa, O., Kuroiwa, T., Yamazaki, F., Kido, R., Mechanism of interferon-γ action: characterisation of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-γ and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263 (1988), 2041–2048.
149. Takikawa, O., Tagawa, Y.-I., Iwakura, Y., Yoshida, R., Truscott, R.J.W., Interferon-gamma-dependent/independent expression of indoleamine 2,3-dioxygenase. Adv. Exp. Med. Biol. 467 (1999), 553–557.
150. Tanaka, T., Knox, W.E., The nature and mechanism of the tryptophan pyrrolase (peroxidase-oxidase) reaction of Pseudomonas and rat liver. J. Biol. Chem. 234 (1959), 1162–1170.
151. Taylor, A.K., Cao, W., Vora, K.P., De La Cruz, J., Shieh, W.-J., Zaki, S.R., Katz, J.M., Sambhara, S., Gangappa, S., Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice. J. Infect. Dis., 2012, 10.1093/infdis/jis527.
152. Terness, P., Bauer, T.M., Röse, L., Dufter, C., Watzlik, A., Simon, H., Opelz, G., Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase–expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med., 194, 2002 447–457.1314-1320.
153. Theofylaktopoulou, D., Midttun, Ø., Ulvic, A., Uelsand, P.M., Tell, G.S., Vollset, S.E., Nygärd, O., Eussen, S.J.P.M., A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clin. Exp. Immunol. 173 (2013), 121–130.
154. 6 as determinants of kynurenines and related markers of interferon-γ-mediated immune activation in the community-based Hordaland Health Study. Br. J. Nutr. 112 (2014), 1065–1072.
155. Thomas, D.R., Shaw, D.M., Tidmarsh, S.F., Effect of aging on plasma tryptophan. J. Clin. Psychopharmacol. 6 (1986), 251–252.
156. Tricklebank, M.D., Pickard, F.J., de Souza, S.W., Free and bound tryptophan in human plasma during the perinatal period. Acta Paediat. Scand. 68 (1979), 199–204.
157. Truswell, A.S., Hansen, J.D.L., Wannenburg, P., Plasma tryptophan and other amino acids in pellagra. Am. J. Clin. Nutr. 21 (1968), 1314–1320.
158. Viru, A., Janson, T., Viru, M., Effect of prolonged exercise on liver tryptophan oxygenase activity in rat. Biol. Sports 22 (2005), 29–33.
159. Von Bubnoff, D., Matz, H., Frahnert, C., Rao, M.L., Hanau, D., de la Salle, H., Bieber, T., FcepsilonR1 induces the tryptophan degradation pathway involved in regulating T cell responses. J. Immunol. 169 (2002), 1810–1816.
160. Werner, E.R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G., Wachter, H., Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-y. Biochem. J. 262 (1989), 861–866.
161. Werner, E.R., Werner-Felmayer, G., Substrate and cofactor requirements of indoleamine 2,3-dioxygenase in interferon-gamma-treated cells: ultilization of oxygen rather than superoxide. Curr. Drug Metab. 8 (2007), 97–101.
162. Wurtman, R.J., Wurtman, J.J., Regan, M.M., McDermott, J., Tsay, R.H., Breu, J.J., Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. Am. J. Clin. Nutr. 77 (2003), 128–132.
163. Yamaguchi, K., Shimoyama, M., Gholson, R.K., Measurement of tryptophan pyrrolase in vivo: induction and feedback inhibition. Biochim. Biophys. Acta Enzymol. 146 (1967), 102–110.
164. Yamazaki, F., Kuroiwa, T., Takikawa, O., Kido, R., Human indolylamine 2,3-dioxygenase, its tissue distribution, and characterisation of the placental enzyme. Biochem. J. 230 (1985), 635–638.
165. Yoshida, R., Hayaishi, O., Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide (lung/endotoxin). Proc. Natl. Acad. Sci. U. S. A., 75, 1978 3998–3400.
166. Yoshida, R., Urade, Y., Tokuda, M., Hayaishi, O., Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc. Natl. Acad. Sci. U. S. A. 76 (1979), 4084–4086.
167. Young, S.N., Sourkes, T.L., Tryptophan catabolism by tryptophan pyrrolase in rat liver: the effect of tryptophan loads and changes in tryptophan pyrrolase activity. J. Biol. Chem. 250 (1975), 5009–5014.
168. Young, S.N., Smith, S.E., Pihl, R.O., Ervin, F.R., Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacol. Berl. 87 (1985), 173–177.
169. Zanardo, V., Casson, L., Costa, C., Biasiolo, M., Allegri, G., Vicenti, E., Grella, P., Level of total and free tryptophan in maternal and in umbilical blood of infants born by vaginal delivery and by elective cesarian section. Biol. Neonate 48 (1985), 346–350.